Clinical Trial Update: STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating stroke secondary prevention using catheter ablation and edoxaban in patients with non-valvular atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Edoxaban (edoxaban)
• catheter ablation

Snippet

Sponsor: Nippon Medical School | Conditions: Ischemic Stroke, Atrial Fibrillation Non-Rheumatic | Phase 3 | Status: UNKNOWN